Company Filing History:
Years Active: 2025
Title: Innovations by Jae Sang Ko in Nasolacrimal Duct Treatment
Introduction
Jae Sang Ko is an innovative inventor based in Seoul, South Korea. He has made significant contributions to the field of medical devices, particularly in the treatment of nasolacrimal duct obstruction. His work focuses on developing solutions that enhance patient care and improve surgical outcomes.
Latest Patents
Jae Sang Ko holds a patent for a nasolacrimal duct insertion member comprising a shape memory polymer. This invention is designed for the treatment of nasolacrimal duct obstruction or stenosis. The unique feature of this insertion member is that it includes a crosslinkable functional group, allowing it to have a melting point suitable for implantation into a living body. This innovation represents a significant advancement in the medical field, providing a new option for patients suffering from this condition.
Career Highlights
Throughout his career, Jae Sang Ko has been associated with TMD Lab Co. Ltd., where he has been instrumental in developing cutting-edge medical technologies. His dedication to research and development has led to advancements that benefit both healthcare professionals and patients alike.
Collaborations
Jae Sang Ko has collaborated with notable colleagues, including Hak-Joon Sung and Jin Sook Yoon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jae Sang Ko's contributions to the field of medical devices, particularly through his patented invention, highlight his commitment to improving healthcare solutions. His work continues to inspire advancements in the treatment of nasolacrimal duct conditions.